Pathology of Layer V Pyramidal Neurons in the Prefrontal Cortex of Patients With Schizophrenia

The University of Illinois institutional review board and the Mental Health Research Center in Moscow (Russia) approved the research, and consent from each family was obtained. Subject selection, diagnostic approach, and neuropathological examination have been described previously (10). The criteria for subject inclusion were a short postmortem interval and cardiovascular disease or pneumonia as the cause of death. The exclusion criteria were ischemic, degenerative, or metabolic disorders and a history of head trauma, brain neoplasm, or alcohol or drug abuse. The schizophrenic subjects included eight women and seven men with a mean age of 59.9 years (SD=17.0) and a mean postmortem interval of 6.0 hours (SD=1.6). They were inpatients in Moscow psychiatric hospitals and had been diagnosed before admission or in the hospitals, in which they resided for a mean of 18 years. ICD-10 diagnoses of schizophrenia for all 15 patients were confirmed independently by two senior Russian psychiatrists (including D.O.) using chart reviews and family interviews. The comparison subjects included two women and 16 men with a mean age of 50.6 years (SD=11.6) and a postmortem interval of 5.4 hours (SD=0.9). They were inpatients or outpatients from Moscow community hospitals and had no history of psychiatric disorders, as determined from medical records and family interviews. (A table describing the subjects can be obtained from Dr. Greenough on request.)

Experienced neuropathologists (including V.V.) performed the autopsies, removing tissue from area 10 (frontal pole, inferior frontal sulcus) of the left hemisphere. Several subcortical regions and cortical areas 10, 38, 17, and 1 were examined for the exclusion criteria (listed in the preceding paragraph) by using the following histopathological stains: Nissl, hematoxylin-eosin, van Gieson, Bielschowsky, and Congo red. Electron microscopy of adjacent blocks showed minimal postmortem changes (9, 10). One subject was excluded for neuropathology (astrocytoma).

A Golgi-Kopsch modification (11) was used to impregnate blocks from area 10, and staining quality and neuron inclusion criteria were assessed without knowledge of diagnosis. Layer V pyramidal neurons with at least two bifurcating basilar dendrites and full impregnation of intact soma and distal dendrites were traced with a camera lucida at 750×. Nine or 10 neurons per subject were randomly selected from multiple fields of view within several 120-μm-thick sections. Three investigators (including I.M.K. and A.W.G.), blind to diagnosis, traced the neurons and counted the intersections between dendrites and a concentric ring overlay (12) to estimate total basilar dendritic field size. Interrater reliability, as indicated by the intraclass correlation coefficient for the three drawers across 14 random subjects, was 0.991 (13).

The mean number of ring intersections per neuron per subject was analyzed by using analysis of variance (ANOVA) (SAS version 8.02; Cary, N.C., SAS Institute), with age and diagnosis as main effects. Type 1 sums of squares were used to account for variance due to age before the effect of diagnosis was tested.

Typical neurons from each group are displayed in Figure 1, which includes results for total ring intersections with basilar dendrites and their spatial distribution relative to the soma. The mean total number of ring intersections per neuron was 78.6 (SD=31.1) for the comparison subjects and 46.8 (SD=11.9) for the schizophrenic subjects. After accounting for age, ANOVA revealed a significant effect of diagnosis on this measure (Figure 1). When included in the model, age and diagnosis did not show a significant interaction. Four of the schizophrenia patients were older than any comparison subject, but analysis without these subjects still indicated a significant effect of diagnosis, as did analyses without the youngest subjects of both groups.

The total basilar dendritic field size of prefrontal layer V pyramidal cells was 40% smaller in these patients with schizophrenia than in normal subjects. These findings are consistent with observations of less neuropil in the prefrontal cortex of patients with schizophrenia, including shorter basilar dendritic length (4, 5) and lower spine density (3, 4) in layer III pyramidal neurons as well as an initial report on layer V basilar dendrites (14). Other findings of ultrastructural synaptic abnormalities (9) and higher pyramidal cell-packing density in layers III (2) and V (8) are also consistent with our results. The reduced prefrontal neuropil may be associated with less dopaminergic innervation of the deep layers of the prefrontal cortex (6).

Although the comparison group had a skewed sex ratio, in the schizophrenia group there was no effect of sex on the number of ring intersections. When the men were analyzed separately (after accounting for age), the effect of diagnosis on ring intersections remained significant (F=9.83, df=2, 20, p=0.006). Prolonged medication may have contributed to reduced neuropil, but prior neuroleptic studies do not support this view (15), and medication history did not appear to correlate with dendritic field size within these subjects. This finding of less layer V pyramidal dendritic material in high-quality postmortem tissue, combined with previous reports, suggests that schizophrenia is associated with profound, multifocal disturbances of connectivity in the prefrontal cortex.

Presented in part at the 28th annual meeting of the Society for Neuroscience, Los Angeles, Nov. 7–12, 1998, and at the International Congress for Schizophrenia Research, Santa Fe, N.Mex., April 17–21, 1999. Received May 30, 2001; revisions received May 7, 2002, and March 27, 2003; accepted Aug. 28, 2003. From the Departments of Psychiatry and Psychology and the Beckman Institute, University of Illinois at Urbana-Champaign; and the Mental Health Research Center, Russian Academy of Medical Sciences, Moscow. Address reprint requests to Dr. Greenough, Beckman Institute, 405 North Mathews Ave., Urbana, IL 61801; [email protected] (e-mail). Funded by the McDonnell Foundation. The authors thank Abhay Laddu and members of the Laboratory of Clinical Neuropathology at the Mental Health Research Center in Moscow.